Status:
UNKNOWN
A Clinical Study to Evaluate the Efficacy of Biologics in SpA
Lead Sponsor:
The University of Hong Kong-Shenzhen Hospital
Conditions:
Spondyloarthritis (SpA)
Eligibility:
All Genders
18-65 years
Brief Summary
Spondyloarthritis (SpA) is one of the potentially debilitating inflammatory diseases that affect the whole body, primarily burdening the sacroiliac joints and the spine. It mostly affects young and mi...
Eligibility Criteria
Inclusion
- \- Diagnosed with non-radiographic or radiographic axial SpA
Exclusion
- Unable to provide written consent
- Unable to undergo MRI examination
- Pregnancy
- Unable to read and/or write Chinese
Key Trial Info
Start Date :
January 12 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04399382
Start Date
January 12 2022
End Date
December 1 2022
Last Update
June 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jin-Xian
Shenzhen, Guangdong / 广东, China, 518000